CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 20 enrolled
Drug / intervention
Lipitor +1 moredrug
Likely dose
Lipitor 40mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00529542
NCT00529542Phase 2Completed
CompareCT.gov

A Six-week Double Blinded, Randomized Trial of Atorvastatin for the Treatment of PCOS Women With Elevated LDL Cholesterol

Milton S. Hershey Medical Center·interventional·Posted Sep 14, 2007·Updated Sep 25, 2014

In Brief

A Phase 2 clinical trial evaluating Lipitor and Placebo for Polycystic Ovary Syndrome. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the efficacy of Lipitor (Atorvastatin) for the treatment of PCOS with elevated LDL cholesterol.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPolycystic Ovary Syndrome
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 14, 2007
Enrollment StartDec 1, 2004
Primary CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 18.8 years ago

Interventions

Lipitordrug

40mg caplets per day for six weeks

Placebodrug

1 placebo caplet per day for six weeks.